Cargando…
Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
AIMS: This study aims at evaluating the metrics of glycemic control in people with type 1 diabetes using the hybrid closed loop (HCL) system during the COVID-19 lockdown. METHODS: This is a retrospective study of thirty adults with type 1 diabetes using HCL and followed with telemedicine at an Itali...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486201/ https://www.ncbi.nlm.nih.gov/pubmed/32926958 http://dx.doi.org/10.1016/j.diabres.2020.108440 |
_version_ | 1783581299659767808 |
---|---|
author | Longo, Miriam Caruso, Paola Petrizzo, Michela Castaldo, Filomena Sarnataro, Annalisa Gicchino, Maurizio Bellastella, Giuseppe Esposito, Katherine Maiorino, Maria Ida |
author_facet | Longo, Miriam Caruso, Paola Petrizzo, Michela Castaldo, Filomena Sarnataro, Annalisa Gicchino, Maurizio Bellastella, Giuseppe Esposito, Katherine Maiorino, Maria Ida |
author_sort | Longo, Miriam |
collection | PubMed |
description | AIMS: This study aims at evaluating the metrics of glycemic control in people with type 1 diabetes using the hybrid closed loop (HCL) system during the COVID-19 lockdown. METHODS: This is a retrospective study of thirty adults with type 1 diabetes using HCL and followed with telemedicine at an Italian University Hospital. Data on metrics of glucose control were collected at different times: two weeks before the lockdown (Time 0), first two weeks of lockdown (Time 1), last two weeks of lockdown (Time 2) and first two weeks after the lockdown (Time 3). The primary endpoint was the change in glucose management indicator (GMI) across the different time points. RESULTS: GMI did not worsen over time (Time 1 vs Time 3, 7% vs 6.9%, P < 0.05), whereas a reduction of mean glucose (P = 0.004) and indices of glucose variability was observed. Time in range (TIR) significantly increased (68.5% vs 73.5%, P = 0.012), and time above range (TAR) level 2 (251–400 mg/dL) significantly decreased (P = 0.002). The improvement of TIR and glucose variability was mainly observed in participants < 35 years. CONCLUSIONS: Adults with type 1 diabetes using HCL showed a significant improvement of most of the metrics of glucose control during the COVID-19 lockdown. |
format | Online Article Text |
id | pubmed-7486201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74862012020-09-14 Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy Longo, Miriam Caruso, Paola Petrizzo, Michela Castaldo, Filomena Sarnataro, Annalisa Gicchino, Maurizio Bellastella, Giuseppe Esposito, Katherine Maiorino, Maria Ida Diabetes Res Clin Pract Article AIMS: This study aims at evaluating the metrics of glycemic control in people with type 1 diabetes using the hybrid closed loop (HCL) system during the COVID-19 lockdown. METHODS: This is a retrospective study of thirty adults with type 1 diabetes using HCL and followed with telemedicine at an Italian University Hospital. Data on metrics of glucose control were collected at different times: two weeks before the lockdown (Time 0), first two weeks of lockdown (Time 1), last two weeks of lockdown (Time 2) and first two weeks after the lockdown (Time 3). The primary endpoint was the change in glucose management indicator (GMI) across the different time points. RESULTS: GMI did not worsen over time (Time 1 vs Time 3, 7% vs 6.9%, P < 0.05), whereas a reduction of mean glucose (P = 0.004) and indices of glucose variability was observed. Time in range (TIR) significantly increased (68.5% vs 73.5%, P = 0.012), and time above range (TAR) level 2 (251–400 mg/dL) significantly decreased (P = 0.002). The improvement of TIR and glucose variability was mainly observed in participants < 35 years. CONCLUSIONS: Adults with type 1 diabetes using HCL showed a significant improvement of most of the metrics of glucose control during the COVID-19 lockdown. Elsevier B.V. 2020-11 2020-09-12 /pmc/articles/PMC7486201/ /pubmed/32926958 http://dx.doi.org/10.1016/j.diabres.2020.108440 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Longo, Miriam Caruso, Paola Petrizzo, Michela Castaldo, Filomena Sarnataro, Annalisa Gicchino, Maurizio Bellastella, Giuseppe Esposito, Katherine Maiorino, Maria Ida Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy |
title | Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy |
title_full | Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy |
title_fullStr | Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy |
title_full_unstemmed | Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy |
title_short | Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy |
title_sort | glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the covid-19 pandemic in italy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486201/ https://www.ncbi.nlm.nih.gov/pubmed/32926958 http://dx.doi.org/10.1016/j.diabres.2020.108440 |
work_keys_str_mv | AT longomiriam glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly AT carusopaola glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly AT petrizzomichela glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly AT castaldofilomena glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly AT sarnataroannalisa glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly AT gicchinomaurizio glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly AT bellastellagiuseppe glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly AT espositokatherine glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly AT maiorinomariaida glycemiccontrolinpeoplewithtype1diabetesusingahybridclosedloopsystemandfollowedbytelemedicineduringthecovid19pandemicinitaly |